X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

KROS

Closed

Keros Therapeutics inc

13.34
-0.01 (-0.07%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 13.35
Day's Range: 13.3 - 13.64
Send
When Written:
 
40.14
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on the development of novel therapeutics for the treatment of rare diseases. The company's lead product candidate, KER-050, is a first-in-class, engineered ligand trap that is designed to address the underlying cause of anemia in patients with myelodysplastic syndromes and myelofibrosis. Keros Therapeutics is also developing a pipeline of other product candidates that target various disease pathways, including those involved in fibrosis and cancer. The company was founded in 2015 and is headquartered in Lexington, Massachusetts.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X